Beam Therapeutics Inc.BEAMNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-15.96%
↓ 114% below average
Average (7y)
113.54%
Historical baseline
Range
High:478.14%
Low:-19.50%
Volatility
438.3%
High variability
| Period | Value |
|---|---|
| 2024 | -15.96% |
| 2023 | 40.37% |
| 2022 | -19.50% |
| 2021 | 275.16% |
| 2020 | 88.91% |
| 2019 | 61.25% |
| 2018 | 478.14% |
| 2017 | 0.00% |